Clinical trial
TCM Syndrome Differentiation Treatment on Reducing the Rehospitalization Rate of Discharged Elderly Patients With CAP:A Multi-center, Randomized, Double-blind Controlled Trial
NCT04702074 is registered in ClinicalTrials.gov with Henan University of Traditional Chinese Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TCM Syndrome Differentiation Treatment on Reducing the Rehospitalization Rate of Discharged Elderly Patients With CAP:A Multi-center, Randomized, Double-blind Controlled Trial
- Lead sponsor
- Henan University of Traditional Chinese Medicine
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 15, 2021
- Completion date
- December 30, 2022
- Enrollment
- 292 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.